Khosla Rachna 4

What Happened

• Rachna Khosla, Senior Vice President, Business Development at Amgen, disposed of 225 shares on May 2, 2026 to satisfy tax obligations related to equity compensation. The transactions were two disposals of 117 shares ($38,589) and 108 shares ($35,621) at $329.82 per share, totaling roughly $74,210.
• These dispositions were reported as payments of exercise price or tax liability (transaction code F), i.e., shares were used/withheld to cover taxes rather than an open-market sale for investment reasons.

Key Details

• Transaction date: May 2, 2026; Filing date: May 5, 2026.
• Prices and amounts: 117 shares @ $329.82 = $38,589; 108 shares @ $329.82 = $35,621; total 225 shares ≈ $74,210.
• Shares owned after transaction: not specified in the details provided in this summary.
• Footnote: 73 of the shares relate to Dividend Equivalents (DEs) credited to unvested Restricted Stock Units under Amgen’s equity incentive plan; DEs are paid out in shares on vesting (see footnote F1).
• Transaction code F indicates the shares were surrendered/withheld to cover tax liability (common for vested awards).

Context

• This appears to be a routine tax-withholding/share-surrender related to equity awards (including dividend equivalents on RSUs), not a discretionary open-market sale. For retail investors, such transactions typically reflect compensation mechanics rather than a signal about the insider’s view of the stock.